These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1569)

  • 1. [Nonachlasine--a new drug for treatment of ischemic heart disease].
    Kaverina NV; Markova GA; Chichkanov GG; Chumburidze VB; Basaeva AI
    Kardiologiia; 1975 Jul; 15(7):43-8. PubMed ID: 1569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cordaron and nonachlasine in treatment of chronic coronary insufficiency].
    Metelitsa VI; Matveeva LS; Borisova GA; Lupanov VP
    Kardiologiia; 1975 Jul; 15(7):48-51. PubMed ID: 1570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of the effect of anti-angina drugs with adrenergic beta receptor agonist action on the collateral hemodynamics and redistribution of the blood flow in chronic myocardial ischemia].
    Chichkanov GG; Bogolepov AK; Matsievskiĭ DD
    Kardiologiia; 1981 Oct; 21(10):85-8. PubMed ID: 6117671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology of a new anti-angina preparation, nonachlazin].
    Kaverdina NV; Markova GA
    Farmakol Toksikol; 1975; 38(2):173-7. PubMed ID: 1227883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of the antianginal action of nonachlazine].
    Chumburidze VB
    Farmakol Toksikol; 1976; 39(1):46-50. PubMed ID: 943317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of antianginal agents with a beta-adrenostimulating component of their action on the ischemic myocardium].
    Kaverina NV; Chichkanov GG; Bogolepov AK; Azvolinskaia TN; Matsievskiĭ DD
    Farmakol Toksikol; 1982; 45(4):37-41. PubMed ID: 6127232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative study of the effect of ethacizin and lidocaine on the blood supply and function of the intact and ischemic myocardium].
    Goldshteĭne GKh; Chichkanov GG
    Biull Eksp Biol Med; 1984 Oct; 98(10):466-9. PubMed ID: 6498326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new beta-2 adrenoceptor agonist (pirbuterol) in the treatment of ischaemic heart failure.
    Nelson GI; Silke B; Barker MC; Saxton CA; Taylor SH
    Eur Heart J; 1982 Jun; 3(3):238-45. PubMed ID: 6125392
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of patients with ischemic heart disease with nonachlasine].
    Dubova GA; Davydova RG; Markova GA
    Klin Med (Mosk); 1974 Oct; 52(10):47-50. PubMed ID: 4437071
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of the hypotensive action of prazosin.
    Constantine JW; McShane WK; Scriabine A; Hess HJ
    Postgrad Med; 1975 Nov; Spec No():18-35. PubMed ID: 1197141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the effect of nitroglycerin on the hemodynamics and contractile function of6the myocardium using electrokymography].
    Kuznetsova VP
    Kardiologiia; 1969 Dec; 9(12):104-7. PubMed ID: 4986574
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D
    Angiology; 1977 Dec; 28(12):839-43. PubMed ID: 23714
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic and renal hemodynamic effects of a new alpha-adrenergic blocking agent: NC 7197.
    Lohmöller RM; Lohmöller GJ; Frohlich ED
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):170-80. PubMed ID: 4147750
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of the effect of ildamen and nonachlazin on the blood supply and activities of the heart].
    Kaverina NV; Chichkanov GG; Chumburidze VB
    Kardiologiia; 1978 Mar; 18(3):88-93. PubMed ID: 642245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The protective action of vasocyclin (prostacyclin) on the ischemic myocardium].
    Kazanova GV; Tsorin IB; Chirkova EIu; Chichkanov GG
    Farmakol Toksikol; 1991; 54(3):24-7. PubMed ID: 1915814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The mechanism of nonachlazine on cardiac activity and blood supply].
    Kaverina NV; Griglevskiĭ R; Basaeva AI; Markova GA; Chumburidze VB
    Biull Eksp Biol Med; 1975 Nov; 80(11):48-50. PubMed ID: 1218260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stimulators of beta-adrenergic structures in treatment of ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Abinder AA; Iankin VV; Kitaeva IT
    Kardiologiia; 1975 Jul; 15(7):37-43. PubMed ID: 1568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of the antianginal action of oxyfedrine].
    Chichkanov GG; Chumburidze VB
    Farmakol Toksikol; 1977; 40(3):302-6. PubMed ID: 20326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of imipramine on the vasomotor tone, blood supply and activity of the heart].
    Chichkanov GG
    Farmakol Toksikol; 1977; 40(6):710-4. PubMed ID: 598497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.